Literature DB >> 21107280

Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease.

Ramiro Juncos1, Luis Juncos, Robert P Hebbel, Gregory M Vercellotti, Zvonimir S Katusic, Karl A Nath.   

Abstract

Sickle cell disease (SCD), the most common inherited hematologic disorder in the United States and the most common single gene disorder in the world, causes substantial morbidity and mortality. The major pathobiologic processes that underlie SCD include vaso-occlusion, inflammation, procoagulant processes, hemolysis, and altered vascular reactivity. The present study examined the vasoactive response to a-adrenergic activation in a murine model of SCD. Isolated aortas from sickle mice as compared with wild-type mice exhibit heightened contractions to norepinephrine and phenylephrine; such responses were completely blocked by an a1-receptor antagonist, prazosin. Aortas from either group exhibited comparable contractile responses to potassium chloride and the thromboxane agonist U46619 and no contractile response to an a2-adrenergic receptor agonist, UK14304. We conclude that there is an exaggerated vasoconstrictive response to a1-receptor agonists in SCD. Because sickle crisis is induced by diverse forms of stress, the latter attended by increased adrenergic activity, our findings may be relevant to the occurrence of sickle crisis. We also suggest that such heightened reactivity may contribute to vaso-occlusive processes that underlie ischemic injury in SCD. Finally, our findings urge caution in the use of phenylephrine in patients with SCD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21107280      PMCID: PMC3131975          DOI: 10.1097/FJC.0b013e318204bb34

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  22 in total

Review 1.  The perfusion paradox and vascular instability in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic; Mark T Gladwin
Journal:  Microcirculation       Date:  2004-03       Impact factor: 2.628

2.  Sickle cell disease: selected aspects of pathophysiology.

Authors:  T Alexy; S Sangkatumvong; P Connes; E Pais; J Tripette; J C Barthelemy; T C Fisher; H J Meiselman; M C Khoo; T D Coates
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

3.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 4.  Priapism in sickle cell disease.

Authors:  Zora R Rogers
Journal:  Hematol Oncol Clin North Am       Date:  2005-10       Impact factor: 3.722

5.  Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death?

Authors:  J C Romero Mestre; A Hernández; O Agramonte; P Hernández
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

6.  Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease.

Authors:  K A Nath; V Shah; J J Haggard; A J Croatt; L A Smith; R P Hebbel; Z S Katusic
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-12       Impact factor: 3.619

7.  A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.

Authors:  Robert P Hebbel; Greg Vercellotti; Karl A Nath
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2009-12

8.  Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.

Authors:  M Phelan; S P Perrine; M Brauer; D V Faller
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Anthony J Croatt; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-27

Review 10.  Drug-induced priapism. Its aetiology, incidence and treatment.

Authors:  J E Baños; F Bosch; M Farré
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb
View more
  2 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

2.  Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.

Authors:  Gabriela Calhoun; Li Wang; Luis E F Almeida; Nicholas Kenyon; Nina Afsar; Mehdi Nouraie; Julia C Finkel; Zenaide M N Quezado
Journal:  Eur J Pharmacol       Date:  2015-02-25       Impact factor: 4.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.